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Purpose: To report the clinical course of a patient with central serous chorioretinopathy (CSCR) secondary to
subclinical hypercortisolism before and after adrenalectomy.
Observations: A 50-year-old female patient with multifocal, chronic CSCR was found to have an adrenal inci
dentaloma and was diagnosed with subclinical hypercortisolism. Patient elected to undergo minimally-invasive
adrenalectomy and presented at 3 months after surgery without subretinal fluid.
Conclusions and Importance: Subclinical Cushing’s Syndrome (SCS) may present an underrecognized risk factor for
developing chronic CSCR. Further investigation is needed to determine the threshold of visual comorbidity that
may influence surgical management.

1. Introduction
Central serous chorioretinopathy (CSCR) is characterized by accu
mulation of fluid in the subretinal or sub-RPE space, often with conse
quential visual impairment. Chronic CSCR has been reported as a
manifestation of hypercortisolism due to Cushing’s syndrome and sub
clinical hypercortisolism.1,2 However, the latter is often underrecog
nized owing to its inherently subtle nature and the optimal threshold for
intervention based on associated comorbidities remains unclear. Herein
we report the clinical course of a patient with CSCR secondary to sub
clinical hypercortisolism before and after adrenalectomy.
2. Case report
A 50-year-old female presented with blurred, discolored spots in the
right eye for several months. Her past medical history included mild
hypertension treated with amlodipine. Past ocular and family history
were noncontributory.
On exam, Snellen visual acuity was 20/50 OD, 20/25 OS. Her pupils,
intraocular pressure, and anterior segment exam were within normal
limits. Dilated fundus exam revealed bilateral, multifocal areas of sub
retinal fluid and mottled pigmentary changes (Fig. 1A). Optical coher
ence tomography confirmed areas of subretinal fluid and other areas of
outer retinal atrophy (Fig. 1B). Fundus autofluorescence revealed areas

of hyperautofluorescence that highlighted the fundoscopic findings
(Fig. 1C). Fluorescein angiography showed multifocal areas of expansile
dot leakage (Fig. 1D). Altogether these findings were consistent with
multifocal, chronic CSCR.
On further clinical follow-up, an adrenal incidentaloma (AI) was
detected when the patient underwent imaging for back pain. Subse
quently she saw an endocrinologist; she had a normal serum cortisol, but
low ACTH and an abnormal dexamethasone suppression test. This led to
a diagnosis of subclinical hypercortisolism and provided a reason for her
hypertension and chronic CSCR.
Since the blur and relative scotomata interfered with her daily ac
tivities, she elected to try eplerenone, which yielded a moderate but
suboptimal therapeutic response at 50 mg daily. While contemplating
photodynamic therapy, in discussion with her endocrinologist, the pa
tient opted to undergo minimally-invasive adrenalectomy. At last
follow-up 3 months after surgery and 6 years after her initial presenta
tion, she has been off eplerenone and without subretinal fluid (Fig. 2).
3. Discussion
CSCR has previously been associated with many risk factors
including exposure to excess steroid. A recent study analyzing a na
tionally representative dataset of 35,000 patients found that patients
with CSCR had a higher odds of Cushing’s syndrome (OR 2.19, 95% CI
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Fig. 1. Multimodal imaging of bilateral multifocal central serous chorioretinopathy. Fundus photographs reveal multifocal subretinal fluid and pigmentary changes
(Fig. 1A). Optical coherence tomography demonstrates subretinal fluid and outer retinal atrophy (Fig. 1B). Areas of hyperautofluorescence highlight the fundoscopic
findings of subretinal fluid (Fig. 1C). Fluorescein angiography showing multiple areas of expansile dot leakage (Fig. 1D).

phenotypic manifestations of Cushing’s syndrome.4 Since adrenal inci
dentaloma has an estimated prevalence of 1–8% of the population,5 it is
quite possible that SCS is an underrecognized risk factor for CSCR.
SCS may potentiate metabolic syndrome and osteoporosis; studies
have found that surgical resection of adrenal incidentalomas improve
weight, blood pressure, and glucose control. Consequently, some au
thors recommend those with SCS-associated comorbidities be consid
ered for resection.6 An important consideration in these patients is how
visual comorbidity factors into intervention. In our patient’s case, the
recurrent CSCR, hypertension, and increased risk of metabolic syndrome

1.33 to 3.59, p = 0.002) than exposure to exogenous steroids (OR 1.14,
95% CI 1.09 to 1.19, p < 0.001)1 Our case highlights the importance of
thorough medication reconciliation and careful consideration of co
morbid conditions in patients with chronic CSCR.
In recent years, subtle endogenous hypercortisolism, termed sub
clinical Cushing’s syndrome (SCS), has been of particular interest in the
endocrinology literature because it can be a challenging diagnosis and
the most appropriate management remains controversial.3 In general,
SCS is comprised of: 1) the presence of an adrenal incidentaloma or
mass, 2) biochemical confirmation of cortisol excess, and 3) no classic
2
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Fig. 2. Optical coherence tomography imaging at presentation and at last follow-up 3 months after adrenalectomy. There is a significant improvement in subretinal
fluid in both eyes, though outer retinal irregularity remains.

were sufficient reasons to elect to have surgery.
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In summary, SCS is a condition of subtle cortisol dysregulation that
may represent an underrecognized risk factor for chronic CSCR. Further
investigation is needed to determine the threshold of visual comorbidity
that may influence surgical management.
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